Powerful new synthetic vaccines to combat epidemics

A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings reveal exceptionally promising results for the Chikungunya vaccine candidate, which has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.

Read more

Viruses as modulators of interactions in marine ecosystems

Viruses are mainly known as pathogens – often causing death. However, scientists are now showing how viruses influence the biology of living marine predators. This sheds new light on the general role of viruses in ocean ecosystems. For these insights, the scientists integrated a suite of innovative and high technology methods that have not been applied simultaneously in the study of marine ecosystems.

Read more

New fungus-derived antibiotic: Relief in sight for immunocompromised people

Infections that are treatable in healthy people can often be fatal in immunocompromised individuals (people with a weak immune system), and hence, they require specialized treatment. Eushearilide is already known to be active against a wide range of pathogenic fungi and yeasts, but its antibacterial properties have not been explored. Now, scientists have derived a new compound from eushearilide and demonstrated its antibacterial and antifungal properties. It can be used to treat lung infections, meningitis, and encephalitis.

Read more

Symbiosis as a tripartite relationship

While viruses are typically known for their pathogenic properties, new research findings now also demonstrate a positive influence of bacteriophages on the interaction of host organisms with bacteria. A new study sheds new light on the symbiosis between multicellular organisms and their microbial communities, which may be regulated by bacteriophages in a tripartite relationship.

Read more

Breakthrough in understanding enzymes that make antibiotic for drug-resistant pathogen

One of the WHO's 3 critical priority pathogens, Acinetobacter baumannii, for which new antibiotics are urgently needed is one step closer to being tackled, as researchers have made a breakthrough in understanding the enzymes that assemble the antibiotic enacyloxin.

Read more